CAMP
CAMP
NASDAQ · Biotechnology

Camp4 Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks
$3.84
+0.25 (+6.96%)
As of Feb 8, 2:05 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +212.8% upside
Low Target $8.14
Average Target $12.01
High Target $13.09
Current Price $3.84
Current
$3.84
Target
$12.01
$8.14 $12.01 avg $13.09
Scenario Analysis
Bear Case
$8.14
112.0%
Low target
Base Case
$12.01
+212.8%
Avg target
Bull Case
$13.09
+240.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$14.38
-73.3% from high
52-Week Low
$5.65
+-32.0% from low
Target vs 52W High
$12.01
-16.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%